Musk’s Neuralink Brain-Chip Receives Approval For Human Trials
Summary from AllSides News Team
Elon Musk’s brain-chip startup, Neuralink, received FDA approval to conduct human trials.
Key Quote: “The first human patient will soon receive a Neuralink device,” Musk stated in a post on X, formerly known as Twitter, “This ultimately has the potential to restore full body movement. In the long term, Neuralink hopes to play a role in AI risk civilizational risk reduction by improving human to AI (and human to human) bandwidth by several orders of magnitude. Imagine if Stephen Hawking had had this.”
Details: The brain-chip implant pairs with a Neuralink app, which “decodes movement intention from brain signals recorded by the N1 Implant, allowing you to control a computer with your thoughts.” The company is seeking test subjects who have “quadriplegia (limited function in all 4 limbs) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) and are at least 1-year post-injury (without improvement),” are 22 years old or older, and have a “consistent and reliable caregiver.” The study is estimated to take roughly six years. The FDA previously denied Neuralink's bid to conduct human trials in 2022, citing safety concerns.
How the Media Covered It: Outlets across the spectrum reported on Neuralink’s human trial approval and subsequent call for trial volunteers. In tandem with reporting on the trial announcement, some left-rated outlets resurfaced reports that monkeys involved in previous Neuralink trials were euthanized after suffering complications from the brain-chip. Musk denied these reports, stating the company intentionally chose “terminal [monkeys] (close to death already).”
Featured Coverage of this Story
From the CenterMusk's Neuralink to start human trial of brain implant for paralysis patients
Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its brain implant for paralysis patients.
Those with paralysis due to cervical spinal cord injury or amyotrophic lateral sclerosis may qualify for the study, it said, but did not reveal how many participants would be enrolled in the trial, which will take about six years to complete.
The study will use a robot to surgically place a brain-computer interface (BCI) implant in...
From the RightMusk’s Neuralink to start human trials for brain implants
Elon Musk‘s Neuralink has received approval from an independent review board to begin human testing for its brain implant technology, the company announced Tuesday.
The human trials will focus on those who have suffered cervical spinal cord injuries and will take about six years to complete. Test subjects will have the chip, a brain-computer interface, inserted into their heads. The company said the initial goal is to get the human test subjects to operate a computer mouse and keyboard with their thoughts alone.
The announcement comes after a lengthy and...
From the LeftNeuralink is recruiting subjects for the first human trial of its brain-computer interface
A few months after getting FDA approval for human trials, Neuralink is looking for its first test subjects. The six-year initial trial, which the Elon Musk-owned company is calling “the PRIME Study,” is intended to test Neuralink tech designed to help those with paralysis control devices. The company is looking for people with quadriplegia due to vertical spinal cord injury or ALS who are over the age of 22 and have a “consistent and reliable caregiver” to be part of the study.
The PRIME Study (which apparently stands for Precise...